BioMark Engages Stockhouse.com Deal Room with Private Placement
F1-Press_Release_-_Engage_Stock_House_Deal_Room_-_June_2016 (PDF) ———————————————
BioMark Closes Second Tranche of Private Placement Offering
F-Press_Release_-_Second_Tranche_Private_Placement_-_$0_15_units_-_June_2016 (PDF) ———————————————
Biomark Receives Approval For Its Lung Cancer Treatment Protocol
Press Release – BUX – Expansion of Cancer Platform (PDF) ———————————————
BioMark Closes First Tranche Of Private Placement Offering
Press Release – Biomark Closes Partial Private Placement-March 15th 2016 (PDF) ———————————————
BioMark Announces Progress Towards Data Analysis
BioMark Announce Progress Towards Data Analysis (PDF) ———————————————
BioMark AGM
BioMark is holding its Annual General and Special Meeting on September 17, 2015 at 925 W Georgia Street #1820, Vancouver, BC. We look forward to seeing you at the meeting. For more information, please visit SEDAR DOWNLOAD AGM MATERIALS FORM OF PROXY (PDF) NOTICE OF MEETING (PDF) MANAGEMENT INFORMATION CIRCULAR (PDF)
BioMark Diagnostics to Conduct Validation Studies for its Patented Assays in Patients with Lung Cancer Dr. James Bond of Surrey Memorial Hospital to act as Principal Investigator
BioMark Diagnostics to Conduct Validation Studies (PDF) ———————————————
BioMark Diagnostics to Conduct Validation Studies for its Patented Assays in Patients with Lung CancerDr. James Bond of Surrey Memorial Hospital to act as Principal Investigator
BioMark Diagnostics to Conduct Validation Studies (PDF) ———————————————
BioMark Diagnostics Receives Clearance from Health Canada to Commence Clinical Trial with Patented Non-Invasive, Urine-Based Assay to Measure Response to Treatment for Lung Cancer
Sept 9thBioMark Diagnostics Receives Clearance from Health Canada (PDF) ———————————————
BioMark Diagnostics Announces Progress in Assay Validation for Clinical Sample Analysis
BioMark Diagnostics Announces Progress in Assay Validation for Clinical Sample Analysis_1 (PDF) ———————————————